Literature DB >> 1958199

Identification and characterization of islet amyloid polypeptide in mammalian gastrointestinal tract.

M Miyazato1, M Nakazato, K Shiomi, J Aburaya, H Toshimori, K Kangawa, H Matsuo, S Matsukura.   

Abstract

We identified and determined the content and molecular form of islet amyloid polypeptide (IAPP/amylin) in the gastrointestinal (GI) tract of human, rat, mouse and cat. IAPP was isolated by anti- IAPP- IgG immunoaffinity chromatography and reverse-phase high performance liquid chromatography coupled with radioimmunoassays for human and rat/mouse IAPPs. Human IAPP [1-37], [17-37] and [24-37] were identified in human stomach with IAPP [1-37] being the major molecular form. In the GI tract of rat, mouse and cat, IAPP [1-37] and IAPP [19-37] were identified with the latter being the major molecular form. IAPP is present from stomach to colon with the highest concentration being observed in pyloric antrum of stomach. IAPP content in rat antrum fell to 69% of control after 4 days of fasting, with the molar ratio of IAPP [19-37] to IAPP [1-37] increasing from 1.4 in controls to 2.9 in fasted rats. Identification of IAPP and characteristic morphology of IAPP- cells in the GI tract indicate a possible biological function of IAPP as a gastrointestinal peptide.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1958199     DOI: 10.1016/s0006-291x(05)81416-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Amylin given by central or peripheral routes decreases gastric emptying and intestinal transit in the rat.

Authors:  G Clementi; A Caruso; V M Cutuli; E de Bernardis; A Prato; M Amico-Roxas
Journal:  Experientia       Date:  1996-07-15

Review 2.  Amylin-mediated control of glycemia, energy balance, and cognition.

Authors:  Elizabeth G Mietlicki-Baase
Journal:  Physiol Behav       Date:  2016-02-27

Review 3.  Role of Cholesterol and Phospholipids in Amylin Misfolding, Aggregation and Etiology of Islet Amyloidosis.

Authors:  Sanghamitra Singh; Saurabh Trikha; Diti Chatterjee Bhowmick; Anjali A Sarkar; Aleksandar M Jeremic
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 4.  Mediators of Amylin Action in Metabolic Control.

Authors:  Christina N Boyle; Yi Zheng; Thomas A Lutz
Journal:  J Clin Med       Date:  2022-04-15       Impact factor: 4.964

5.  Activation of calcitonin receptor and calcitonin receptor-like receptor by membrane-anchored ligands.

Authors:  Chia Lin Chang; Jae-Il Park; Sheau Yu Teddy Hsu
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

6.  Immunoreactivity and expression of amylin in gastroenteropancreatic endocrine tumors.

Authors:  R Eissele; C Neuhaus; M E Trautmann; A Funk; R Arnold; H Höfler
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

7.  Islet amyloid polypeptide gene expression in the endocrine pancreas of the rat: a combined in situ hybridization and immunocytochemical study.

Authors:  H Mulder; A C Lindh; F Sundler
Journal:  Cell Tissue Res       Date:  1993-12       Impact factor: 5.249

Review 8.  Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases.

Authors:  Nina Sonne; Morten A Karsdal; Kim Henriksen
Journal:  Mol Metab       Date:  2020-11-07       Impact factor: 7.422

9.  Regulation of amylin release from cultured rabbit gastric fundic mucosal cells.

Authors:  Ian L P Beales; John Calam
Journal:  BMC Physiol       Date:  2003-10-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.